DSIP, or delta sleep-inducing peptide, is often marketed online for sleep, but Chia does not offer DSIP. Before trying to buy any peptide, patients should verify whether it is prescribed by a licensed clinician, dispensed by a legitimate pharmacy, and supported by human evidence for the intended use.
Wondering if NAD+ is right for you? Take the 3-min clinical quiz.
See if you qualify →What is DSIP peptide?
DSIP means delta sleep-inducing peptide. It is a short chain of amino acids that was first described in sleep research and has since been studied in small human and laboratory studies for sleep, stress-response biology, pain signaling, and hormone patterns 6, 7.
The name can make DSIP sound simple: take a peptide, sleep better. The evidence is not that clean. Older human studies used different designs and endpoints, and modern insomnia guidelines do not list DSIP as a recommended treatment for chronic insomnia 8.
Quick facts about DSIP
Delta sleep-inducing peptide is best understood as an investigational peptide, not a standard sleep medication. The most important facts are about evidence, access, and safety, not marketing claims.
What DSIP stands for
DSIP stands for delta sleep-inducing peptide. “Delta” refers to slow-wave brain activity seen during deeper stages of sleep, though the peptide’s role in human sleep remains uncertain 6.
Whether Chia offers DSIP
Chia does not currently offer DSIP peptide. We only describe DSIP here for education because people often find it through no-prescription online sellers.
Why online peptide buying can be risky
The main risk is not just whether a checkout page exists. The risk is buying an injected or intranasal product with no licensed clinician review, unclear ingredients, uncertain sterility, and no plan for side-effect monitoring. FDA has warned patients to be cautious with online pharmacies that sell prescription medicines without a valid prescription 4.
What to ask before using any peptide
- Is a licensed clinician reviewing your health history first?
- Is the product being dispensed by a state-licensed pharmacy?
- Is a prescription required when one is legally needed?
- Are the active ingredient, route, and strength clearly listed?
- Is there follow-up care if you have side effects or no benefit?
Can you legally buy DSIP peptide online?
Buying DSIP online is not the same thing as getting a legitimate prescription medication. A website may sell DSIP as a “research chemical,” but that does not mean it is FDA-approved, appropriate for human use, or safely dispensed for a patient.
For prescription-style peptide therapy, the safer access model is a licensed clinician evaluation followed by dispensing through a legitimate pharmacy when treatment is clinically appropriate. FDA’s BeSafeRx program warns that unsafe online pharmacies may sell products with too much, too little, or the wrong active ingredient, or products that were not stored correctly 4.
Is DSIP approved for sleep or other medical uses?
DSIP is not FDA-approved for insomnia, sleep quality, circadian rhythm problems, anxiety, pain, hormone support, or any other medical use in the United States. Searches of FDA approval resources do not identify an approved DSIP drug product 5.
That matters because FDA approval is the process that evaluates a drug’s safety, effectiveness, manufacturing quality, labeling, and use instructions for a specific indication. Without that review, patients should be careful not to treat online claims as proof.
What does the evidence say about DSIP?
DSIP evidence is limited and older. Some early human studies explored sleep architecture and insomnia symptoms, but the findings were mixed and the research base is not strong enough for DSIP to appear in major insomnia treatment guidelines 7, 8.
For chronic insomnia, the American Academy of Sleep Medicine guideline supports cognitive behavioral therapy for insomnia, often called CBT-I, as a core treatment approach 8. Medication decisions depend on the patient’s age, other conditions, medication list, sleep pattern, and risks such as falls, next-day sedation, or substance use.
| Question | DSIP | Better-established sleep care |
|---|---|---|
| FDA-approved for insomnia? | No FDA-approved DSIP product was identified in FDA approval resources 5. | Some prescription sleep medicines are FDA-approved for specific insomnia uses; choice depends on clinician review. |
| Guideline role | Not listed as a recommended insomnia treatment in major sleep guidelines 8. | CBT-I is recommended as a core treatment for chronic insomnia 8. |
| Evidence base | Small and older human studies with mixed findings 7. | Larger evidence base for behavioral sleep care and selected approved medications. |
| Main safety concern | Unknown product quality and limited human safety data, especially from no-prescription online sellers. | Known risks still exist, but a clinician can match care to the patient and monitor side effects. |
What are the safety concerns with DSIP?
DSIP safety is hard to judge because it lacks modern, large, controlled human trials for common online uses. Possible concerns include unknown purity, incorrect strength, contamination, injection-site problems if injected, nasal irritation if used intranasally, allergic reactions, and interactions with other sleep-affecting drugs or alcohol.
Compounding can be appropriate when done under the right legal and clinical conditions, but compounded drugs are not FDA-approved and do not go through FDA premarket review for safety, effectiveness, or manufacturing quality 3. This is why clinician review and pharmacy legitimacy matter.
Sleep complaints also deserve a real evaluation. Insomnia can overlap with sleep apnea, restless legs syndrome, depression, anxiety, thyroid disease, menopause symptoms, pain, stimulant use, alcohol use, or circadian rhythm disruption. A peptide cannot replace that workup.
How can patients evaluate an online peptide seller?
Online peptide access should start with a medical model, not a cart model. A legitimate path should make it clear who evaluates you, who dispenses the product, what you are receiving, and how side effects are handled.
Licensed clinician review
A licensed clinician should review your health history, medications, allergies, goals, and red flags before any prescription treatment. For sleep complaints, this review may also screen for sleep apnea risk, mental health symptoms, alcohol use, and medication causes.
Prescription requirement
Be cautious if a site sells prescription-style peptide products for human use with no prescription and no clinical review. FDA warns that online pharmacies that bypass prescription safeguards may sell unsafe, ineffective, or counterfeit products 4.
State-licensed pharmacy dispensing
If a medication is compounded, it should come from a properly licensed pharmacy. At Chia, medications we offer are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door when prescribed after review.
Clear ingredient and dose information
A patient should be able to see the active ingredient, form, route, and strength on the prescription label. This article does not provide DSIP dosing instructions because dosing should not be guessed from online forums or product listings.
Follow-up care and side-effect monitoring
A real treatment plan includes follow-up. Patients should know how to reach the care team, what side effects to report, and when to stop and seek urgent care.
Does Chia offer DSIP peptide?
Chia does not offer DSIP in our current treatment catalog. We do offer certain longevity and peptide-related treatments where a licensed US provider reviews each patient and prescribes only when clinically appropriate.
Why DSIP is not in Chia’s current treatment catalog
DSIP is not part of Chia’s current public catalog. We do not present it as an available prescription option, and we do not route patients toward DSIP ordering.
What peptide and longevity treatments Chia does offer
For patients asking about peptide therapy more broadly, Chia’s current catalog includes sermorelin in injection, nasal spray, and tablet forms; NAD+ in injection and nasal spray forms; glutathione in injection and nasal spray forms; GHK-Cu cream; and PT-141 nasal spray. These are not DSIP substitutes, and each has its own evidence limits, risks, and eligibility criteria.
| Chia treatment | Forms listed in Chia’s current catalog | Current starting price | Important note |
|---|---|---|---|
| Sermorelin | Injection, nasal spray, tablets | Injection and nasal spray plans currently start at $179/mo | Used only after licensed-provider review; not a DSIP equivalent. |
| NAD+ | Injection, nasal spray | Nasal spray plans currently start at $119/mo; injection plans currently start at $179/mo | A longevity-focused option; evidence and goals differ from sleep medications. |
| Glutathione | Injection, nasal spray | Plans currently start at $179/mo | An antioxidant-related treatment; not an insomnia treatment. |
| GHK-Cu | Cream | Plans currently start at $159/mo | A topical peptide-related option; not a DSIP alternative. |
| PT-141 | Nasal spray | Plans currently start at $159/mo | A sexual-health-related peptide option; not a sleep peptide. |
How Chia’s online clinician-review process works
Chia is 100% online. A patient completes a short health questionnaire, then a licensed US provider reviews it and prescribes only when clinically appropriate. A prescription is never guaranteed. When medication is prescribed, it is compounded by a US state-licensed 503A pharmacy and shipped to the patient’s door. Patients can message their care team through the portal between visits.
What alternatives should someone discuss with a clinician?
Sleep complaints deserve a cause-first plan. A clinician may ask about your sleep schedule, caffeine, alcohol, medications, mood, pain, snoring, breathing pauses, hot flashes, shift work, and screen timing before discussing any product.
For chronic insomnia, CBT-I is a guideline-supported approach and can help people change the habits and conditioned arousal that keep insomnia going 8. If medication is considered, the choice should be individualized and weighed against side effects such as next-day sedation, falls, memory issues, drug interactions, or dependence risk.
If your interest is longevity or peptide therapy rather than insomnia, it may be more useful to discuss your actual goal with a clinician: energy, recovery, skin health, sexual function, hormone symptoms, or weight care. That helps avoid using a sleep-marketed peptide for a problem it may not fit.
Some websites sell DSIP without a prescription, often as a research chemical. That does not mean it is approved, safe, or appropriate for human use. For any prescription-style peptide therapy, a licensed clinician should evaluate you first.
No. DSIP stands for delta sleep-inducing peptide. Sermorelin is a different peptide related to growth-hormone signaling. Chia offers sermorelin in injection, nasal spray, and tablet forms after clinician review, but sermorelin is not a DSIP substitute.
No. DSIP is not a GLP-1 medication. GLP-1 medications, such as semaglutide, are used in weight-care settings. DSIP is an investigational peptide often marketed online for sleep.
No. Chia does not currently offer or prescribe DSIP peptide. Chia’s current catalog includes other treatments, but availability does not guarantee that any treatment is right for a specific patient.
Compounded medications are not FDA-approved. When Chia offers a compounded treatment, it requires licensed-provider review and is dispensed through US state-licensed 503A compounding pharmacies when clinically appropriate.
Do not rely on an online seller for medical advice. Consider contacting a licensed clinician, especially if you have used the product, had side effects, take other medications, are pregnant, or have a chronic condition. Seek urgent care for severe allergic symptoms, chest pain, trouble breathing, fainting, or severe confusion.
The evidence is limited and mixed. DSIP is not part of major insomnia treatment guidelines. If you have ongoing insomnia, a clinician can help evaluate causes and discuss evidence-based options.
References
- 1.U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee Meeting, July 23–24, 2026: Meeting Materials and 503A Bulks List Nominations. FDA, 2026.
- 2.Drug Topics. FDA Advisory Committee Recommends Six Peptides for 503A Bulks List, Declines Emideltide/DSIP. Drug Topics, 2026.
- 3.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA, 2024.
- 4.U.S. Food and Drug Administration. BeSafeRx: Know Your Online Pharmacy. FDA, 2025.
- 5.U.S. Food and Drug Administration. Drugs@FDA: FDA-Approved Drugs Database. FDA, 2026.
- 6.Schoenenberger GA, Monnier M. Characterization of a Delta-Electroencephalogram-Sleep-Inducing Peptide. Proceedings of the National Academy of Sciences of the United States of America, 1977.
- 7.Schneider-Helmert D, Schoenenberger GA. Effects of Delta-Sleep-Inducing Peptide on Sleep in Man. Neuropsychobiology, 1981.
- 8.Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, Sateia MJ, Troxel WM, Zhou ES, Kazmi U, Heald JL, Martin JL. Behavioral and Psychological Treatments for Chronic Insomnia Disorder in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine, 2021.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if NAD+ is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
